Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae-Reference-Cited by-同舟云学术

Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae

Published:2017-10-04 Issue:12 Volume:72 Page:3374-3381
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Fransen Fiona,Hermans Kelly,Melchers Maria J B,Lagarde Claudia C M,Meletiadis Joseph,Mouton Johan W

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/12/3374/21899375/dkx328.pdf

Reference29 articles.

1. Phosphonomycin, a new antibiotic produced by strains of streptomyces;Science,1969

2. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review;Lancet Infect Dis,2010

3. In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa;J Antimicrob Chemother,2015

4. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections;Int J Antimicrob Agents,2006

5. Fosfomycin tromethamine—a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections;Drugs,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Intravenous Fosfomycin in Clinical Practice: A 5-Year Retrospective Study in a Tertiary Hospital in Italy;Antibiotics;2023-05-27

2. Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study;Annals of Clinical Microbiology and Antimicrobials;2023-04-24

3. Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers;European Journal of Clinical Pharmacology;2023-04-15

4. In vitro efficacy of fosfomycin against E. coli and prevalence of MDR and XDR E. coli isolates from UTI Patients;Journal of Rawalpindi Medical College;2023-04-01

5. In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates;Antibiotics;2023-01-23